Today: 15 May 2026
Rivian’s R2 Moment Is Here, and Traders Are Betting the Next Move Could Be Sharp
25 April 2026
2 mins read

Rivian’s R2 Moment Is Here, and Traders Are Betting the Next Move Could Be Sharp

San Francisco — April 25, 2026, 09:09 PDT

  • Rivian kicked off R2 production, marking a crucial test for its push past the premium EV segment.
  • Options markets have pegged a significant move ahead of April 30 earnings.
  • Investors have moved past the survival narrative; now it’s about how well the company delivers. Price levels and the risks tied to scaling up, though, are still in play.

Rivian Automotive has kicked off production on its R2 SUV, shifting its headline vehicle from concept to reality just days ahead of quarterly earnings. The new model comes in at a lower price, targeting a broader customer base beyond Rivian’s R1 lineup and taking direct aim at Tesla’s Model Y. CFO Claire McDonough told Reuters the company is “encouraged” by R2 reservations, though she didn’t share figures. Reuters

Investors are bracing for a closer look at the ramp, with Rivian set to post its first-quarter numbers on April 30 after markets close at 5 p.m. ET. Shares last changed hands at $16.52, putting Rivian’s market cap around $20.2 billion.

Nervousness is showing up in the options market. According to TipRanks/The Fly on Friday, Rivian slipped 48 cents to around $16.47, as options implied odds of a swing greater than 8.73%, or $1.44, around the next report—basically a coin flip for that kind of move. Traders are leaning harder on downside hedges too, with the put-call skew steepening.

That was a less upbeat tone than what we saw earlier this week. TipRanks/The Fly flagged “moderately bullish” action in Rivian—shares picked up 59 cents, or 3.44%, closing around $17.74. Options volume hit 122,000 contracts, with calls outpacing puts. TipRanks

Production kicked off just days after a weather incident rattled Rivian’s facility in Normal, Illinois. TechCrunch reported an EF-1 tornado ripped away a section of the factory’s roof, yet CEO RJ Scaringe told Bloomberg Television there would be “not making any changes to the plan.” TechCrunch

The numbers tell the story: Rivian’s R2 Performance launches at $57,990 in spring 2026. Premium trim? That’s $53,990, but it won’t show up until late 2026. Standard Long Range follows, slated for 2027 at $48,490. Then a lower-priced Standard version, which Rivian says should land in late 2027, targeting a starting price near $45,000.

Bulls got more than just hype this time: Rivian’s first-quarter numbers are in. The company’s filing reports 10,236 vehicles produced at Normal and 10,365 delivered for the quarter ending March 31. That 2026 delivery forecast hasn’t budged—still targeting between 62,000 and 67,000 vehicles.

Rivian’s R2 is a linchpin for its autonomy ambitions. Last month, Uber committed as much as $1.25 billion to Rivian through 2031, pegged to a set of autonomous tech milestones. Uber—and its fleet affiliates—aim to buy 10,000 R2 robotaxis capable of full autonomy, plus an option on another 40,000 units in 2030.

Rivian now steps into the wider robotaxi fray alongside Tesla and Alphabet’s Waymo, both already well entrenched in investor conversations. Uber’s agreement with Rivian marks another move to diversify its autonomous-vehicle supply chain—doubling down on multiple suppliers instead of putting all its chips on a single tech player.

The retail crowd is making more noise with the launch approaching. Yahoo Finance spotlighted an Insider Monkey article that recapped a bullish Substack argument for Rivian, pitching RIVN as a potential “re-rating opportunity” following its slide from post-IPO levels. As of April 21, shares were at $17.15, the piece noted. Insider Monkey

Motley Fool’s Ryan Vanzo recently pointed to two things that might give Rivian a shot at a 10x return over the long run: the R2 rollout and its ambitions in AI and autonomy. Still, Vanzo flagged the AI angle as a big ‘wait and see’—it’s just too soon to call.

Still, there’s a danger investors are pricing in a smoother rollout than Rivian might actually manage. Last month, D.A. Davidson’s Michael Shlisky warned that Rivian faces pressure to pull off the strongest midsize EV debut in five years—all while lacking federal tax credits and a wide dealer base. Cantor Fitzgerald’s Andres Sheppard, for his part, described the R2 as Rivian’s “most material catalyst” for the year. MarketWatch

Come Thursday night, Rivian faces the task of threading together production, pricing, order flow, and spending—one narrative. For the moment, there’s a real new vehicle rolling out, and Wall Street isn’t done hedging.

Stock Market Today

  • Expeditors International Shares Rise 6% Amid Valuation Debate
    May 15, 2026, 1:11 PM EDT. Expeditors International of Washington (EXPD) has gained about 6% in the last month, driven by optimism around its global logistics operations. The stock price stands near US$153.61, delivering a 1-year shareholder return of 35.2%. However, the company's price-to-earnings (P/E) ratio of 24x is considered high versus the global logistics industry average of 15.8x and the peer average of 20.3x, suggesting potential overvaluation. Analysts note the stock trades at a 9.2% discount to fair value per discounted cash flow models but warn that P/E ratios could decline if growth expectations weaken. With revenue and net income both forecast to grow around 4%, investors remain cautious about whether the current price fully reflects future growth prospects or if risks could temper sentiment.

Latest articles

Grab Stock Just Hit a Fresh 52-Week Low — Why Investors Still Aren’t Buying the Profit Beat

Grab Stock Just Hit a Fresh 52-Week Low — Why Investors Still Aren’t Buying the Profit Beat

15 May 2026
Grab Holdings shares hit a 52-week low of $3.46 in New York Friday, despite first-quarter revenue rising 24% to $955 million and profit reaching $120 million. Investors sold amid concerns over Indonesia’s new rule capping ride-hailing commissions at 8%, down from 20%. Grab said its Indonesian business model will need changes but downplayed the impact, noting two-wheel rides make up less than 6% of mobility volume.
Bitmine Stock Slides as Tom Lee’s $13.4 Billion Ethereum Bet Enters a New Test

Bitmine Stock Slides as Tom Lee’s $13.4 Billion Ethereum Bet Enters a New Test

15 May 2026
Bitmine Immersion Technologies shares dropped 7.7% Friday in New York as ether slid 3.4% to $2,221. Bitmine reported holding 5.2 million ETH, or 4.31% of supply, and plans to slow weekly ETH purchases. Peer Bit Digital said Q1 revenue fell 13.6% and ETH staking revenue dropped 29.4%. Polymarket traders put a 24% chance on Bitmine selling ETH in 2026.
Apple’s OpenAI Deal Hits Legal Turbulence Before WWDC AI Reveal

Apple’s OpenAI Deal Hits Legal Turbulence Before WWDC AI Reveal

15 May 2026
OpenAI is considering legal action against Apple after their ChatGPT-iPhone partnership failed to deliver deeper integration and subscription growth, sources told Reuters and the Financial Times. OpenAI’s lawyers are working with an outside firm on possible breach-of-contract steps. Apple is expected to detail more AI plans at WWDC, set for June 8-12. Apple shares rose about 1% Friday.
IREN Stock Drops After $3 Billion Debt Deal: Why Nvidia’s AI Bet Just Got More Expensive

IREN Stock Drops After $3 Billion Debt Deal: Why Nvidia’s AI Bet Just Got More Expensive

15 May 2026
IREN closed a $3.0 billion convertible senior notes sale to fund its shift from bitcoin mining to AI data centers. Shares fell $3.94 to $54.46 late Friday morning after the announcement. The offering follows a $3.4 billion AI cloud contract and a 5GW infrastructure partnership with Nvidia. IREN reported a wider net loss of $247.8 million for the March quarter as it decommissioned mining hardware.
The Trade Desk Stock Just Got a Short-Squeeze Signal. Earnings Could Decide the Next Move
Previous Story

The Trade Desk Stock Just Got a Short-Squeeze Signal. Earnings Could Decide the Next Move

Intellia Therapeutics Stock Jumps After Hours Ahead of First Phase 3 In Vivo CRISPR Readout
Next Story

Intellia Therapeutics Stock Jumps After Hours Ahead of First Phase 3 In Vivo CRISPR Readout

Go toTop